跳至主要内容
临床试验/PACTR201911466695052
PACTR201911466695052已完成未知

Efficacy of a Single dose versus Triple Dose Regimen of Mebendazole against Hookworm infection among School Children: Randomized trial.

niversity of Gondar0 个研究点目标入组 108 人开始时间: 2019年11月26日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Year(s) 至 12 Year(s)(—)
性别
All

入选标准

  • Written informed consent signed by parents and/or legal guardians; and a verbal assent (children <18 years) according to Ethiopian regulation.
  • Able and willing to be examined by a study physician at the beginning of the study.
  • Able and willing to provide required stool samples at the beginning (baseline) and two to three weeks after treatment (follow-up).
  • Positive for hookworm eggs in the stool.
  • No recent anthelminthic treatment (within past 4 weeks).
  • Negative pregnancy test (girls =12 years)
  • Apparently health individual; based on medical history, physical examination, vital signs, hemoglobin level were included
  • Children who were able to chew the drug were subjected for randomization
  • Participant had hemoglobin level above 8g/dl

排除标准

  • Individual who has taken any form of medication containing mebendazole or any other treatment for STH infection within 30 days of entry into the study
  • Who had diarrhea at the time of the first sampling,
  • Who experience a severe concurrent medical condition,
  • Participant with haemoglobin level below 8g/dl,
  • Child with known history of allergic reaction to mebendazole, and
  • Participants infected with other parasitic infection were excluded from the allocated treatment

研究者

发起方
niversity of Gondar

相似试验